X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/beactica-therapeutics-tead-programme-selected-for-late-breaking-research-presentation-at-the-aacr-annual-meeting-2024-302061530.html
https://www.prnewswire.com/news-releases/beactica-therapeutics-to-present-breakthrough-in-yaptead-programme-at-the-hippo-pathway-drug-development-summit-2023-301825604.html
https://www.prnewswire.com/news-releases/beactica-therapeutics-to-present-update-on-lsd1-programme-at-the-aacr-annual-meeting-2023-301794233.html
https://www.prnewswire.com/news-releases/beactica-therapeutics-and-oscotec-mutually-agree-to-conclude-oncology-collaboration-301789278.html
https://www.prnewswire.com/news-releases/beactica-therapeutics-receives-fda-orphan-drug-designation-for-bea-17-for-the-treatment-of-glioblastoma-301735895.html
https://www.prnewswire.com/news-releases/dong-a-st-and-beactica-therapeutics-mutually-agree-to-conclude-oncology-collaboration-301618002.html
https://www.prnewswire.com/news-releases/oscotec-and-beactica-therapeutics-announce-license-and-collaboration-agreement-to-develop-new-cancer-drug-301238176.html
https://www.prnewswire.com/news-releases/oscotec-and-beactica-therapeutics-announce-license-and-collaboration-agreement-to-develop-new-cancer-drug-301238176.html
https://www.biospectrumasia.com/news/25/15019/dong-a-st-with-beactica-to-develop-new-cancer-treatments.html
Market Place
Share 
